Holen Sie sich die Stockscreener-App
0.8598
8.03%
0.0639
Schlusskurs vom Vortag:
$0.7959
Offen:
$0.8175
24-Stunden-Volumen:
226.94K
Relative Volume:
1.09
Marktkapitalisierung:
$42.83M
Einnahmen:
$2.82M
Nettoeinkommen (Verlust:
$-13.47M
KGV:
-1.2644
EPS:
-0.68
Netto-Cashflow:
$-13.61M
1W Leistung:
+7.47%
1M Leistung:
+20.76%
6M Leistung:
-24.58%
1J Leistung:
+16.17%
1-Tages-Spanne:
$0.8019
$0.87
1-Wochen-Bereich:
$0.717
$0.87
52-Wochen-Spanne:
$0.3954
$1.39
Neuroone Medical Technologies Corp Stock (NMTC) Company Profile
Firmenname
Neuroone Medical Technologies Corp
Sektor
Branche
Telefon
(952) 426-1383
Adresse
7599 ANAGRAM DR, EDEN PRAIRIE
Vergleichen Sie NMTC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| 0.99 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
0.90 | 1.13B | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.38 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
2.60 | 115.41M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.1534 | 331.46M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DAVEW
Dave Inc
|
1.4425 | 0 | 0 | 0 | 0 | 0.00 |
Neuroone Medical Technologies Corp Stock (NMTC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-05 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2022-03-29 | Herabstufung | Craig Hallum | Buy → Hold |
Neuroone Medical Technologies Corp Aktie (NMTC) Neueste Nachrichten
Does NeuroOne Medical Technologies Corporation qualify in momentum factor screeningFree Alpha Driven Watchlist With Alerts - Newser
Does NeuroOne Medical Technologies Corporation show high probability of reboundFree Confirmed Setup With Expert Accuracy - Newser
Reversal indicators forming on NeuroOne Medical Technologies Corporation stockPattern Breakout Tracker with Screener Tools - Newser
Why NeuroOne Medical Technologies Corporation stock attracts strong analyst attentionFree Short Term Buy Zone Stock Alerts - Newser
What recovery options are there for NeuroOne Medical Technologies CorporationFree Swing Trading Plan With Smart Signals - Newser
Analyzing recovery setups for NeuroOne Medical Technologies Corporation investorsFree Real Trader Watchlist of Hot Stocks - Newser
Exit strategy if you’re trapped in NeuroOne Medical Technologies Corporation - Newser
Can NeuroOne Medical Technologies Corporation hit a new high this monthReal Time Screener for Growth Trades - Newser
Published on: 2025-08-10 05:12:13 - Newser
Published on: 2025-08-08 23:32:40 - Newser
NeuroOne Medical Technologies Corporation stock retracement – recovery analysisAI Screener for Daily Stock Forecast - Newser
Why NeuroOne Medical Technologies Corporation is moving todayPrice Action Trading with Volume Confirmation - Newser
NeuroOne Medical Technologies Corporation Stock Chart Analysis: Bullish or Bearish Pattern FormingConsistent Gain Plan with AI Support - Newser
Will NeuroOne Medical Technologies Corporation outperform the marketInsider Strategy for High Conviction Picks - Newser
What MACD signals say about NeuroOne Medical Technologies CorporationLow Risk Stock Selection Strategy Guide - Newser
Published on: 2025-08-04 09:36:17 - metal.it
What institutional investors are buying NeuroOne Medical Technologies Corporation stockAchieve breakthrough gains with expert advice - Jammu Links News
What indicators show strength in NeuroOne Medical Technologies CorporationFree Real Market Momentum Signal Generator - Newser
What are the technical indicators suggesting about NeuroOne Medical Technologies CorporationAchieve breakthrough profits with expert advice - Jammu Links News
Why is NeuroOne Medical Technologies Corporation stock attracting strong analyst attentionMarket Forecast Alerts To Watch Now - Jammu Links News
NeuroOne Medical Technologies Corporation Stock Performance After Earnings: Historical InsightsAI Volatility Forecast and Risk Monitor - Newser
NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern TimeUpdate - The Globe and Mail
NeuroOne Medical Technologies to Announce Fiscal Q3 2025 Financial Results on August 14, 2025 - Quiver Quantitative
NeuroOne Medical Tech Q3 Earnings Call: Key Updates Coming for Neurological Device Maker - Stock Titan
How to build a dashboard for NeuroOne Medical Technologies Corporation stockFree Low Drawdown Real Time Trading Tips - Newser
What technical models suggest about NeuroOne Medical Technologies Corporation’s comebackHigh Reward Investment Strategy for Beginners - Newser
Published on: 2025-07-29 21:58:21 - metal.it
How did NMTC's Q1 2025 EPS surprise investors? - AInvest
What makes NeuroOne Medical Technologies Corporation stock price move sharplyWeekly Portfolio Update with ROI Focus - Newser
Is NeuroOne Medical Technologies Corporation forming a bottoming baseAlpha Generation Strategy with Low Volatility - Newser
What are NeuroOne Medical Technologies Corporation company’s key revenue driversPre Market Entry Points That Work - Jammu Links News
What indicators show strength in NeuroOne Medical Technologies Corporation Investment Life Cycle Planning Summary - Newser
What is the dividend policy of NeuroOne Medical Technologies Corporation stockGet timely alerts on market movers - Jammu Links News
How volatile is NeuroOne Medical Technologies Corporation stock compared to the marketInvest confidently with daily market forecasts - Jammu Links News
Does NeuroOne Medical Technologies Corporation stock perform well during market downturnsTrack high-yield stocks before they peak - Jammu Links News
Critical Contrast: So-Young International (NASDAQ:SY) vs. NeuroOne Medical Technologies (NASDAQ:NMTC) - Defense World
Company News for Jul 24, 2025 - The Globe and Mail
What drives NeuroOne Medical Technologies Corporation stock priceOverwhelming financial success - Autocar Professional
NeuroOne receives USPTO patent allowance for neural probe technology By Investing.com - Investing.com Nigeria
NeuroOne Medical Technologies Secures Notice of Allowance for Key Neural Probe Patent - Quiver Quantitative
NeuroOne receives USPTO patent allowance for neural probe technology - Investing.com
Finanzdaten der Neuroone Medical Technologies Corp-Aktie (NMTC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.31%
1.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):